Literature DB >> 16544553

[Salmonella enteritidis: an unusual meningitis agent in an adult patient].

Gökhan Metan1, Emine Alp, Duygu Eşel, Bilgehan Aygen, Bülent Sümerkan.   

Abstract

Salmonella species may cause wide spectrum of infections changing from enterocolitis to sepsis. However, Salmonella meningitis in adults is a rare but important clinical condition with a high mortality rate. In this report, a 71 years old male patient with Salmonella enteritidis meningitis who was followed-up with the diagnosis of immune thrombocytopenic purpura and had been administered azothioprin and prednisolone, has been presented and similar cases in the literature have been reviewed. The cerebrospinal fluid culture yielded S. enteritidis, and the isolate was intermediate susceptible to ampicillin, susceptible to cefotaxime, trimethoprim-sulphametoxasole, ciprofloxacin and chloramphenicol. Our patient was successfully treated with ceftriaxone (2 x 2 gr i.v.) and discharged with total cure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16544553

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  4 in total

1.  Bilateral tubo-ovarian abscess and sepsis caused by Salmonella in patients with systemic lupus erythematosus.

Authors:  Selma Guler; Hafize Oksuz; Gozde Yildirim Cetin; Omer Faruk Kokoglu
Journal:  BMJ Case Rep       Date:  2013-09-10

2.  Muscle Abscess due to Salmonella Enterica.

Authors:  Yasemin Akkoyunlu; Bahadir Ceylan; Meryem Iraz; Nuh Mehmet Elmadag; Turan Aslan
Journal:  Iran Red Crescent Med J       Date:  2013-07-05       Impact factor: 0.611

3.  Salmonella enteritidis meningitis in a first time diagnosed AIDS patient: case report.

Authors:  Chrisostomos Katsenos; Nectarios Anastasopoulos; Maria Patrani; Costas Mandragos
Journal:  Cases J       Date:  2008-05-12

4.  Interaction of Antibiotics with Innate Host Defense Factors against Salmonella enterica Serotype Newport.

Authors:  George Sakoulas; Monika Kumaraswamy; Armin Kousha; Victor Nizet
Journal:  mSphere       Date:  2017-12-06       Impact factor: 4.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.